Huahai pharmaceutical: the net profit in the first quarter is expected to decrease by 41% - 50% year-on-year
Huahai pharmaceutical announced that in the first quarter of 2022, the company is expected to realize a net profit attributable to the parent company of 127-150 million yuan, a year-on-year decrease of about 41% - 50%.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Discretionary
Amazon Global Selling: A Decade of Growth in a Vast Market
Dec 17, 2024 05:43 PM
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Consumer Staples
MOIT to Focus on Promoting Economic and Trade Cooperation in 2025
Jan 13, 2025 03:07 PM
Briefing Aug 26, 2021 06:31 PM
· Healthcare
Huahai pharmaceutical: the net profit in the first half of the year was 516 million yuan, a year-on-year decrease of 10.84%
See more
Read next
Insight
In-depth
Automotive · Analysis
Shanghai and Shenzhen: The Dual-City Landscape and Corporate Power
Jan 09, 2025 03:35 PM
Insight
In-depth
Technology, Healthcare · Interview
Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain"
Jan 08, 2025 06:10 PM
Insight
In-depth
Automotive, Technology · Interview
How AI is Driving Globalization and Transformation in Emerging Industries? | Highlights
Jan 08, 2025 05:44 PM
Insight
In-depth
Consumer Staples, Communication · Interview
How Can F&B and Retail Companies Effectively Replicate Local Success Models? | Highlights
Jan 08, 2025 05:09 PM